Prime Medicine shares were 9.2% lower, at $3.90, after the company said the Cystic Fibrosis Foundation has agreed to provide it with up to $24 million in additional funding--including a $6 million ...

BETHESDA, Md. (July 16, 2025) – Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

This shift follows the announcement of initial positive data from the Phase 1/2 clinical trial of PM359 in Chronic ...

Here we have not one but two Technics deals that stand out from the rest. One of these stereo amps is a Product of the Year ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate ...

JMP Securities reiterated its Market Outperform rating and $6.00 price target on Prime Medicine (NASDAQ:PRME) Wednesday following the announcement of the Eli Lilly (NYSE:LLY) and Verve ...

Jamnagar: India and the World Health Organization (WHO) are working in unison in the field of traditional medicine, with the ...

Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- ...

IISc & Tufts University to combat malnutrition & advance metabolic health research with AI & biosensors: Nandita Vijayasimha, Bengaluru Thursday, July 17, 2025, 08:00 Hrs [IST] Th ...

As financial pressures mount and adjacent markets become saturated and/or highly regulated, a growing number of health systems are rethinking the geographic boundaries of traditional mergers and ...